Global DNA Testing Market is anticipated to reach USD
10.04 billion by 2022, according to a new study by Grand View Research Inc.
Rise in developments in the field of genome sequencing and personalized DNA
level diagnostic applications, a considerable growth in the number of patented
research initiatives by the government and government funded projects are
factors expected to drive demand during the forecast period.
Introduction
of novel technologies for genome profiling are expected to boost progress of
this industry over the forecast period. Furthermore, increasing incidences of
chronic oncology and infectious diseases that depend on DNA prototyping for
treatment and diagnosis using personalized medicine are anticipated to
significantly raise demand for DNA diagnostics/testing based research thereby
propelling industrial growth in the coming years. Increasing demand for
prenatal testing and in-vitro fertilization that subsequently
leads to rise in demand for DNA diagnostics/testing is also attributive towards
expected progress in this market.
Browse
Details of Report @
http://www.grandviewresearch.com/industry-analysis/dna-testing-market
http://www.grandviewresearch.com/industry-analysis/dna-testing-market
Further key findings from the study suggest:
- PCR based
diagnosis accounted for the largest share of the market revenue in 2014 as
a result of higher preference rate coupled with higher availability of
products and reagent kits of this segment.
- Next
generation sequencing application for DNA testing is estimated to witness
significant progress with a double digit CAGR of over 16% amongst the
other technology segments due to presence of significant advantages
offered by this technique of DNA identification and testing.
- Infectious
disease diagnostics accounted for the largest market share in 2014 due to
higher incidence rate of various infectious disorders which subsequently
raises the demand for in-vitro nucleic acid based
diagnostic tests for diagnosis and monitoring of disease progression.
- There are
diverse applications of DNA testing market out of which oncology
diagnostics and histopathology is estimated to register lucrative growth
over the forecast period. Factors attributing for considerable growth
potential in this segment include identification of cancer causing genes
& associated research, and facilitation in mutation detection
- North
America dominated the market in 2014, with revenue estimated at over USD
2,600 million. Presence of sophisticated healthcare infrastructure, rising
incidence of genetic abnormalities, favorable government initiatives with
respect to genetic diagnosis and its application in in-vitro fertilization
are major factors driving growth of this region.
- Asia Pacific
is anticipated to witness lucrative growth as a result of developments in
health care infrastructure in this region coupled with presence of
significant number of target population that is suffering with chronic as
well as acute disorders. Government initiatives taken up herein are also
attributive to influence sector growth to a great extent.
- Key
participants of DNA testing industry include Abbott Laboratories, Agilent
Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad
Laboratories, Thermo Fisher Scientific, Applied Biosystems Group, Cepheid
Inc., Transgenomic Inc., Siemens Healthcare, Roche Diagnostics, Qiagen,
Illumina, GE Healthcare, Alere Inc, Affymetrix Inc., Hologic, Dako, and
454 Life Sciences.
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
No comments:
Post a Comment